METASTAT INC by MetaStat, Inc. (MTST)

About METASTAT INC by MetaStat, Inc. (MTST)

MetaStat, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes MetaSite Breast and MenaCalc platforms. The MetaSite Breast test measures the process of systemic metastasis and is intended for early stage breast cancer patients. The MenaCalc, a platform of diagnostic assays, based on the measurement of the balance of the Mena protein isoforms, is broadly applicable in solid epithelial-based cancers, including breast, prostate, lung and colorectal. The company was founded by Warren C. Lau on July 22, 2009 and is headquartered in Boston, MA.

METASTAT INC by MetaStat, Inc. News